Marker Therapeutics Ownership | Who Owns Marker Therapeutics?

Marker Therapeutics Ownership Summary

Marker Therapeutics is owned by 0.83% institutional investors, 12.20% insiders, and 86.98% retail investors. Ar asset management is the largest institutional shareholder, holding 0.79% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.43% of its assets in Marker Therapeutics shares.

MRKR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Marker Therapeutics	0.83%	12.20%	86.98%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ar asset management	70.70K	0.79%	$384.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ar asset management	70.70K	0.09%	$384.00K

Top Buyers

Holder	Shares	% Assets	Change
Ar asset management	70.70K	0.09%	-

Top Sellers

Holder	Shares	% Assets	Change
Ar asset management	70.70K	0.09%	-

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	1	-	73,700	4.24%	-	130.95%	1	-	-	-
Jun 30, 2024	1	-	70,700	-	-	125.86%	-	-	-	-
Mar 31, 2024	1	-	70,700	-	-	123.79%	-	-	-	-
Dec 31, 2023	1	-	70,700	-	-	124.07%	-	-100.00%	-	-
Sep 30, 2023	1	-	70,700	73.71%	-	368.91%	1	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	153.47K	1.43%	-
Vanguard Institutional Extnd Mkt Idx Tr	87.14K	0.81%	-
Fidelity Extended Market Index	39.68K	0.37%	-262.00
WEALTHGATE Biotech Aggressive Fund I	25.44K	0.29%	-
DFA US Small Cap I	15.90K	0.15%	-
iShares Micro-Cap ETF	14.25K	0.13%	-
Fidelity Total Market Index	12.81K	0.12%	-
WEALTHGATE Biotech Fund Inst	9.51K	0.11%	-
Fidelity Series Total Market Index	9.24K	0.09%	-77.00
NT Ext Equity Mkt Idx Fd - NL	5.80K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 23, 2024	ELMS STEVE	-	Buy	$35.47K
Dec 23, 2024	New Enterprise Associates 16, L.P.	-	Buy	$1.77M
Mar 16, 2021	Eansor Norman David	-	Buy	$249.99K
May 18, 2021	Wasserman Frederick Gerald	-	Buy	$24.10K
Mar 16, 2021	Walker Paul Edward	-	Buy	$10.00M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	1	-
2023 Q2	-	-
2023 Q1	-	-
2022 Q2	-	-
2022 Q1	-	-

MRKR Ownership FAQ

Who Owns Marker Therapeutics?

Marker Therapeutics shareholders are primarily institutional investors at 0.83%, followed by 12.20% insiders and 86.97% retail investors. The average institutional ownership in Marker Therapeutics's industry, Biotech Stocks , is 109.70%, which Marker Therapeutics falls below.

Does Blackrock own Marker Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Marker Therapeutics.

Who is Marker Therapeutics’s biggest shareholder by percentage of total assets invested?

Ar asset management is Marker Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.09% of its assets in 70.7K Marker Therapeutics shares, valued at 384K$.

Who is the top mutual fund holder of Marker Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Marker Therapeutics shares, with 1.43% of its total shares outstanding invested in 153.47K Marker Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools